Relacorilant Provides Significant Benefit Across Cardiometabolic Outcomes in Global Statistical Tests of the Placebo-controlled, Randomized-withdrawal GRACE Trial in Cushing Syndrome
Presented: Cardiometabolic Health Conference, 15 October 2026, Boston, MA
Presenter: Austin L Hand, PhD
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.